Significant progress in understanding the pathophysiology of peripartum cardiomyopathy, especially hormonal and genetic mechanisms, has been made. Specific criteria should be used for diagnosis, but the disease remains a diagnosis of exclusion. Both long-term and recurrent pregnancy prognoses depend on recovery of cardiac function. Data from large registries and randomized controlled trials of evidence-based therapeutics hold promise for future improved clinical outcomes.
Keywords: Cardiac disease; Congestive heart failure; Peripartum cardiomyopathy; Pregnancy.
Copyright © 2018 Elsevier Inc. All rights reserved.